Carprofen: A New Nonsteroidal Antiinflammatory Drug Pharmacology, Clinical Efficacy and Adverse Effects
Authors:
- 2 January 1987
- journal article
- clinical trial
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 7 (1) , 16-24
Abstract
Carprofen (Rimadyl, Roche), a new nonsteroidal antiinflammatory drug (NSAID) will soon be commercially available. Not counting aspirin and other salicylates, there arenow at least a dozen NSAIDs commercially available in the United States.Keywords
This publication has 19 references indexed in Scilit:
- A Double Blind Crossover Study of Carprofen and Indomethacin in Patients with Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1983
- NON-STEROIDAL ANTI-INFLAMMATORY AGENTS INHIBIT THE SYNTHESIS OF IgM RHEUMATOID FACTOR IN VITROThe Lancet, 1982
- Quantitation of biliary excretion of drugs in manClinical Pharmacology & Therapeutics, 1982
- The pharmacokinetics and metabolism of 14C‐carprofen in manBiopharmaceutics & Drug Disposition, 1982
- High-performance Liquid Chromatographic Determination of Stereoselective Disposition of Carprofen in HumansJournal of Pharmaceutical Sciences, 1981
- Reproduction studies with carprofen, a nonsteroidal anti-inflammatory agent in ratsToxicology and Applied Pharmacology, 1980
- Metabolism of carprofen, a nonsteroidal anti-inflammatory agent, in rats, dogs, and humansJournal of Pharmaceutical Sciences, 1980
- Stereospecific Assay and Stereospecific Disposition of Racemic Carprofen in RatsJournal of Pharmaceutical Sciences, 1979
- Pharmacokinetics of Carprofen in Plasma and Synovial FluidThe Journal of Clinical Pharmacology, 1979
- Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthetaseProstaglandins, 1975